Petros Pharmaceuticals, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
Petros Pharmaceuticals, Inc. (PTPI) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2022-05-16
- Petros Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2021-06-30 was 0.00 shares.
- Petros Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2021-03-31 was 1.60K shares.
- Petros Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2020-06-30 was 0.00 shares.
- Petros Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2020-03-31 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 6 month |
|---|---|---|
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-16 | 1.50K shares 10-Q · filed 2021-08-16 |
| 2021-03-31 | 1.60K shares 10-Q · filed 2022-05-16 | |
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-08-16 | 0.00 shares 10-Q · filed 2021-08-16 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |